An Open-Label, Single-Arm, Phase II Trial of Buparlisib in Patients with Melanoma Brain Metastases Not Eligible for Surgery or Radiosurgery—the BUMPER Study
Neuro-Oncology Advances(2020)
关键词
buparlisib,melanoma brain metastases,PI3K inhibitors,targeted therapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要